2011•Zhongguo redai yixueRequires access

Bioequivalence assessment of meloxicam granules in Chinese healthy volunteers

Wang Jiu-hui

Open publisher page 0 citations

Abstract

Aim To evaluate the bioequivalence of meloxicam granules in healthy volunteers.Methods The randomized crossover and self-control study was conducted in 20 healthy volunteers.They were treated with a single oral dose of 15mg of meloxicam granules or a single oral dose of control drug(meloxicam tablets).The meloxicam concentrations in plasma were detected by RP-HPLC.Results The mean Tmax was(3.3±1.6)h for meloxicam granules and(4.7±1.1) h for meloxicam tablets;the mean Cmax was(0.652±0.109)and(0.532±0.106)μg/mL respectively;T1/2 was(26.56±11.29) and(26.87±9.99)h respectively;AUCO 96 was(20.083±6.182)and(l8.767±6.165)μg·h/mL respectively;AUC0∞was (23.901±8.624)and(22.452±7.548)μg·h/mL respectively;The relative bioavailability of meloxicam granules was(113.8±35.5)%.Conclusion The meloxicam orally suspension is bioequivalent to the meloxicam tablets.

About this research paper

What this paper is about

Aim To evaluate the bioequivalence of meloxicam granules in healthy volunteers.Methods The randomized crossover and self-control study was conducted in 20 healthy volunteers.They were treated with a single oral dose of 15mg of meloxicam granules or a single oral dose of control drug(meloxicam tablets).The meloxicam concentrations in plasma were detected by RP-HPLC.Results The mean Tmax was(3.3±1.6)h for meloxicam granules and(4.7±1.1) h for meloxicam tablets;the mean Cmax was(0.652±0.109)and(0.532±0.106)μg/mL respectively;T1/2 was(26.56±11.29) and(26.87±9.99)h respectively;AUCO 96 was(20.083±6.182)and(l8.767±6.165)μg·h/mL respectively;AUC0∞was (23.901±8.624)and(22.452±7.548)μg·h/mL respectively;The relative bioavailability of meloxicam granules was(113.8±35.5)%.Conclusion The meloxicam orally suspension is bioequivalent to the meloxicam tablets.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aim To evaluate the bioequivalence of meloxicam granules in healthy volunteers.Methods The randomized crossover and self-control study was conducted in 20 healthy volunteers.They were treated with a single oral dose of 15mg of meloxicam granules or a single oral dose of control drug(meloxicam tablets).The meloxicam concentrations in plasma were detected by RP-HPLC.Results The mean Tmax was(3.3±1.6)h for meloxicam granules and(4.7±1.1) h for meloxicam tablets;the mean Cmax was(0.652±0.109)and(0.532±0.106)μg/mL respectively;T1/2 was(26.56±11.29) and(26.87±9.99)h respectively;AUCO 96 was(20.083±6.182)and(l8.767±6.165)μg·h/mL respectively;AUC0∞was (23.901±8.624)and(22.452±7.548)μg·h/mL respectively;The relative bioavailability of meloxicam granules was(113.8±35.5)%.Conclusion The meloxicam orally suspension is bioequivalent to the meloxicam tablets.

Key concepts: Meloxicam, Bioequivalence, Bioavailability, Cmax, Crossover study, Medicine, Pharmacology, Plasma concentration

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence assessment of meloxicam granules in Chinese healthy volunteers — Research Paper | ScholarLens